Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07276178
Starting soon Observational

Reliability of the Scoliosis Caregiver Response and Emotional Scale (SCaRES) Questionnaire

NCT07276178 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-12-10
Last updated
2025-12-10

Condition(s) studied

Scoliosis IdiopathicScoliosis Idiopathic AdolescentCaregiver Anxiety

Study summary

The aim of this study is to examine the psychometric properties of the Turkish version of the Scoliosis Caregiver Response and Emotional Scale (SCaRES) questionnaire; to evaluate the reliability of the Turkish form and to ensure its usability in clinical and research fields.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals who are an adult (parent or primary caregiver) responsible for the care of an individual diagnosed with scoliosis between the ages of 10 and 18. * Individuals who are able to read and understand Turkish. * Individuals who are actively involved in the child's treatment process (e.g., use of a brace, exercise program, follow-up appointments). * Individuals who volunteer to participate in the study. Exclusion Criteria: * Participants whose children have a history of other comorbidities (neurological, etc.), * Children whose children have a history of spinal surgery, * Individuals who do not have an active role in the care process (e.g., parents who only provide financial support), * Caregivers with intellectual disabilities, serious psychiatric diagnoses, or cognitive impairments that limit communication, * Participants with incomplete or invalid survey forms.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hasan Kalyoncu University Gaziantep Gaziantep

More Hasan Kalyoncu University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07276178 on ClinicalTrials.gov ↗ ← All trials in Turkey